STAT

Tom Marsilje, a relentless advocate for cancer patients, dies at 45

Tom Marsilje was eternally optimistic and willing to give of his time to help his fellow cancer patients find clinical trials and experimental therapies.

When Tom Marsilje launched a website in May to help people with late-stage colorectal cancer find possible treatments through clinical trials, he pointed out the irony: “The ultimate CRC clinical trial advocate is unlikely to ever do a clinical trial,” he said.

He was right.

Marsilje, a Novartis scientist who helped develop a cutting-edge lung cancer treatment — and who, after his own colon cancer diagnosis, became a fierce advocate for his fellow patients — died Tuesday afternoon at a hospital in San Diego. He was 45.

The cancer support community was reeling in the wake of the

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readPolitics
Pelosi’s Drug Pricing Plan Would Let Medicare Negotiate Prices For Up To 250 Drugs
The new legislation is more aggressive than prior concepts that had circulated among lobbyists and congressional staff this year.
STAT3 min readScience
Amid Privacy Concerns, Startup Becomes First Consumer DNA Company To Offer Anonymous Sequencing
Nebula will offer anonymous testing amid public concerns about the privacy of genetic data and law enforcement use of public DNA databases to identify suspects.
STAT5 min readTech
Opinion: Tech Companies’ Dangerous Practice: Using Artificial Intelligence To Mine Hidden Health Data
Like modern day alchemists turning lead into gold, tech companies use machine learning to transform our digital traces into valuable and unprotected health data.